Bissonnette, Robert

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., et al. (2015) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesInflammatory mediators and NSAID effects

Cited by 907

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

Simpson, E. L., Lacour, J. ‐., Spelman, L., Galimberti, R., Eichenfield, L. F., Bissonnette, R., King, B. A., Thyssen, J. P., Silverberg, J. I., Bieber, T., et al. (2020) · British Journal of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 396

Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Renert-Yuval, Y., Thyssen, J. P., Bissonnette, R., Bieber, T., Kabashima, K., Hijnen, D., & Guttman-Yassky, E. (2021) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 350

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Deleuran, M., Thaçi, D., Beck, L. A., de Bruin-Weller, M., Blauvelt, A., Forman, S., Bissonnette, R., Reich, K., Soong, W., Hussain, I., et al. (2020) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 255

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Guttman-Yassky, E., Pavel, A. B., Zhou, L., Estrada, Y. D., Zhang, N., Xu, H., Peng, X., Wen, H.-C., Govas, P., Gudi, G., et al. (2019) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 220

Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent

Bissonnette, R., Stein Gold, L., Rubenstein, D. S., Tallman, A. M., & Armstrong, A. (2021) · Journal of the American Academy of Dermatology

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 181

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Bieber, T., Thyssen, J. P., Reich, K., Simpson, E. L., Katoh, N., Torrelo, A., De Bruin‐Weller, M., Thaci, D., Bissonnette, R., Gooderham, M., et al. (2021) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesDrug-Induced Adverse Reactions

Cited by 152

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

Sofen, H., Bissonnette, R., Yosipovitch, G., Silverberg, J. I., Tyring, S., Loo, W. J., Zook, M., Lee, M., Zou, L., Jiang, G.-L., et al. (2023) · eClinicalMedicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 108

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial: WBI-1001 as a novel topical treatment for atopic dermatitis

Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H. C., Webster, J., Ip, W., Tang, L., & Lyle, M. (2012) · British Journal of Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 92

Prevention and reduction of atrophic acne scars with adapalene 0.3%/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison

Dréno, B., Bissonnette, R., Gagné-Henley, A., Barankin, B., Lynde, C., Kerrouche, N., & Tan, J. (2018) · American Journal of Clinical Dermatology

Acne and Rosacea Treatments and EffectsDermatologic Treatments and Research

Cited by 69

560 KPL-716, anti-Oncostatin M receptor beta antibody, reduced pruritus in atopic dermatitis

Mikhak, Z., Bissonnette, R., Siri, D., Tyring, S. K., Tessari, E., Gandhi, R., Fang, F., & Paolini, J. F. (2019) · Journal of Investigative Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 21

Sensitivity of clinician‐assessed efficacy outcome measurement instruments in trials of topical therapies for atopic dermatitis: a systematic review and meta‐analysis

Légaré, S., Chagnon, M., Palijan, A., Kojok, K., & Bissonnette, R. (2022) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 6

563 ATx201 modulates biomarkers of skin barrier function and cutaneous inflammation in patients with moderate atopic dermatitis

Guttman-Yassky, E., Bissonnette, R., Pavel, A., Saint-Cyr Proulx, E., Prokocimer, P., Toft-Kehler, R., & Sommer, M. (2020) · Journal of Investigative Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 4